TY  - JOUR

T1  - A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer

JO  - British Journal of Cancer

UR  - https://eprints.whiterose.ac.uk/id/eprint/203278

PY  - 2023/08/03

AU  - Macaulay VM

AU  - Lord S

AU  - Hussain S

AU  - Maroto JP

AU  - Jones RH

AU  - Climent M

AU  - Cook N

AU  - Lin C-C

AU  - Wang S-S

AU  - Bianchini D

AU  - Bailey M et al

ED  - 

DO  - DOI: 10.1038/s41416-023-02380-1

PB  - Springer Science and Business Media LLC

VL  - 129

IS  - 6

SP  - 965

EP  - 973

Y2  - 2025/12/05

ER  -